Back to Authors

Knopman, David S.

A5114182124 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 18

NODDI in gray matter is a sensitive marker of aging and early AD changes

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | July 29, 2024 | Volume: 16 | Issue: 3 | Pages: No page available

10.1002/dad2.12627 | PMID 39077685

AbstractINTRODUCTIONAge‐related and Alzheimer's disease (AD) dementia–related neurodegeneration impact brain health. While morphometric measures from T1‐weighted scans are established biomarkers, they may be less sensitive to earlier changes. Neurite orientation dispersion and density imaging (NODDI), offering biologically meaningful interpretation of tissue microstructure, may be an advanced brain health biomarker.METHODSWe contrasted regional gray matter NODDI and morphometric evaluations concerning their correlation with (1) age, (2) clinical diagnosis stage, and (3) tau pathology as assessed by AV1451 positron emission tomography.RESULTSOur study hypothesizes that NODDI measures are more sensitive to aging and early AD changes than morphometric measures. One NODDI output, free water fraction (FWF), showed higher sensitivity to age‐related changes, generally better effect sizes in separating mild cognitively impaired from cognitively unimpaired participants, and stronger associations with regional tau deposition than morphometric measures.DISCUSSIONThese findings underscore NODDI's utility in capturing early neurodegenerative changes and enhancing our understanding of aging and AD.Highlights Neurite orientation dispersion and density imaging can serve as an effective brain health biomarker for aging and early Alzheimer's disease (AD). Free water fraction has higher sensitivity to normal brain aging. Free water fraction has stronger associations with early AD and regional tau deposition.
SMON, clioquinol, and copper

Postgraduate Medical Journal | February 14, 2023 | Volume: 81 | Issue: 954 | Pages: 227-227

10.1093/postgradmedj/81.954.227

The Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Population-Based Study

Journal of Investigative Medicine | January 6, 2023 | Volume: 54 | Issue: 2_suppl | Pages: 375-375

10.1177/108155890605402s95

APOE modifies the association between Aβ load and cognition in cognitively normal older adults

Neurology | December 22, 2011 | Volume: 78 | Issue: 4 | Pages: 232-240

10.1212/wnl.0b013e31824365ab | PMID 22189452

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment

Neurology | June 14, 2011 | Volume: 64 | Issue: 5 | Pages: 902-904

10.1212/01.wnl.0000153076.46126.e9 | PMID 15753434

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology

Neurology | December 31, 2007 | Volume: 70 | Issue: 1 | Pages: 25-34

10.1212/01.wnl.0000287073.12737.35 | PMID 18166704

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

Neurology | September 26, 2007 | Volume: 70 | Issue: 7 | Pages: 512-520

10.1212/01.wnl.0000280575.77437.a2 | PMID 17898323

Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease

Neurology | February 27, 2006 | Volume: 66 | Issue: 4 | Pages: 602-604

10.1212/01.wnl.0000198762.41312.e1 | PMID 16505324